Deva Holding AS (DEVA) - Total Assets
Based on the latest financial reports, Deva Holding AS (DEVA) holds total assets worth TL35.50 Billion TRY (≈ $795.16 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Deva Holding AS for net asset value and shareholders' equity analysis.
Deva Holding AS - Total Assets Trend (2005–2024)
This chart illustrates how Deva Holding AS's total assets have evolved over time, based on quarterly financial data.
Deva Holding AS - Asset Composition Analysis
Current Asset Composition (December 2024)
Deva Holding AS's total assets of TL35.50 Billion consist of 41.3% current assets and 58.7% non-current assets.
| Asset Category | Amount (TRY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | TL0.00 | 3.2% |
| Accounts Receivable | TL4.93 Billion | 16.6% |
| Inventory | TL4.73 Billion | 15.9% |
| Property, Plant & Equipment | TL0.00 | 0.0% |
| Intangible Assets | TL5.86 Billion | 19.7% |
| Goodwill | TL30.86 Million | 0.1% |
Asset Composition Trend (2005–2024)
This chart illustrates how Deva Holding AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Deva Holding AS (DEVA) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Deva Holding AS's current assets represent 41.3% of total assets in 2024, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, up from 2.2% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 4.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 19.7% of total assets.
Deva Holding AS Competitors by Total Assets
Key competitors of Deva Holding AS based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
|
China | CN¥10.96 Billion |
|
Beijing Winsunny Pharmaceutical CO.LTD
SHG:601089
|
China | CN¥4.69 Billion |
|
KPC Pharmaceuticals Inc
SHG:600422
|
China | CN¥12.01 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Cheng Du Sheng Nuo Biotec Co. Ltd. A
SHG:688117
|
China | CN¥1.91 Billion |
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
China | CN¥2.64 Billion |
Deva Holding AS - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.71 | 1.57 | 1.97 |
| Quick Ratio | 1.06 | 0.95 | 1.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | TL6.02 Billion | TL4.49 Billion | TL961.62 Million |
Deva Holding AS - Advanced Valuation Insights
This section examines the relationship between Deva Holding AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.49 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -8.3% |
| Total Assets | TL29.73 Billion |
| Market Capitalization | $322.33 Million USD |
Valuation Analysis
Below Book Valuation: The market values Deva Holding AS's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Deva Holding AS's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Deva Holding AS (2005–2024)
The table below shows the annual total assets of Deva Holding AS from 2005 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | TL29.73 Billion ≈ $665.86 Million |
-8.26% |
| 2023-12-31 | TL32.40 Billion ≈ $725.77 Million |
+275.73% |
| 2022-12-31 | TL8.62 Billion ≈ $193.16 Million |
+69.77% |
| 2021-12-31 | TL5.08 Billion ≈ $113.78 Million |
+64.51% |
| 2020-12-31 | TL3.09 Billion ≈ $69.16 Million |
+45.69% |
| 2019-12-31 | TL2.12 Billion ≈ $47.47 Million |
+27.03% |
| 2018-12-31 | TL1.67 Billion ≈ $37.37 Million |
+32.79% |
| 2017-12-31 | TL1.26 Billion ≈ $28.14 Million |
+23.48% |
| 2016-12-31 | TL1.02 Billion ≈ $22.79 Million |
+2.47% |
| 2015-12-31 | TL992.95 Million ≈ $22.24 Million |
+11.13% |
| 2014-12-31 | TL893.53 Million ≈ $20.01 Million |
+8.09% |
| 2013-12-31 | TL826.63 Million ≈ $18.51 Million |
+14.29% |
| 2012-12-31 | TL723.26 Million ≈ $16.20 Million |
+8.56% |
| 2011-12-31 | TL666.25 Million ≈ $14.92 Million |
+6.98% |
| 2010-12-31 | TL622.80 Million ≈ $13.95 Million |
+17.86% |
| 2009-12-31 | TL528.42 Million ≈ $11.84 Million |
+7.89% |
| 2008-12-31 | TL489.79 Million ≈ $10.97 Million |
+27.13% |
| 2007-12-31 | TL385.28 Million ≈ $8.63 Million |
+32.45% |
| 2006-12-31 | TL290.88 Million ≈ $6.52 Million |
+6.48% |
| 2005-12-31 | TL273.18 Million ≈ $6.12 Million |
-- |
About Deva Holding AS
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more